Cyclooxygenase metabolites in human lung anaphylaxis

Airway vs. parenchyma

E. S. Schulman, N Franklin Adkinson, H. H. Newball

Research output: Contribution to journalArticle

Abstract

We studied the generation of arachidonic acid cyclooxygenase metabolites (AACMs) during in vitro anaphylaxis of passively sensitized human lung parenchymal and airway fragments. Prostaglandins E, F2(α), D2, 6-keto-prostaglandin F1(α), and thromboxane B2 (PGE, PGF2(α), PGD2, 6-keto-PGF1(α), TXB2, respectively) were assayed by radioimmunoassay. Results with airway tissue were compared with subpleural parenchymal fragments from the same lungs similarly challenged. Spontaneous generation of prostacyclin (PGI2), as measured by its stable metabolite 6-keto-PGF1(α), exceeded by two- to threefold other spontaneous AACM release in both bronchial and parenchymal fragments. In airway antigen produced variable AACM responses, but in general the rank order was 6-keto-PGF1(α) > PGE is approx. the same as PGF2(α) > PGD2 > TXB2. The rank for antigen-induced AACM release from parenchyma was 6-keto-PGF1(α) is approx. the same as PGD2 > > PGF2(α) > TXB2 is approx. the same as PGE. In airway, as in parenchyma, very little AACM production during anaphylaxis can be attributed to smooth muscle contraction per se. Histamine released from bronchi (0.67 ± 0.30 μg/g lung) was significantly less than from parenchyma (3.7 ± 0.70 μg/g) despite comparable histamine content. At comparable levels of histamine release, the parenchyma produced greater quantities than bronchi of all AACMs except PGE. The comparatively limited bronchial capacity to generate PGF2(α), PGD2, TXB2, and histamine (airway constrictors) along with predominant generation of PGI2 and PGE (airway relaxants) may help preserve airway patency.

Original languageEnglish (US)
Pages (from-to)589-595
Number of pages7
JournalJournal of Applied Physiology Respiratory Environmental and Exercise Physiology
Volume53
Issue number3
StatePublished - 1982

Fingerprint

Anaphylaxis
Prostaglandin-Endoperoxide Synthases
Prostaglandins E
Dinoprost
Prostaglandin D2
Lung
Epoprostenol
Histamine
Bronchi
Antigens
Thromboxane B2
Histamine Release
Muscle Contraction
Radioimmunoassay
Smooth Muscle
prostaglandin F1

ASJC Scopus subject areas

  • Endocrinology
  • Physiology

Cite this

Cyclooxygenase metabolites in human lung anaphylaxis : Airway vs. parenchyma. / Schulman, E. S.; Adkinson, N Franklin; Newball, H. H.

In: Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, Vol. 53, No. 3, 1982, p. 589-595.

Research output: Contribution to journalArticle

@article{ccefbf9fe9aa4066a295fd9b0b47c263,
title = "Cyclooxygenase metabolites in human lung anaphylaxis: Airway vs. parenchyma",
abstract = "We studied the generation of arachidonic acid cyclooxygenase metabolites (AACMs) during in vitro anaphylaxis of passively sensitized human lung parenchymal and airway fragments. Prostaglandins E, F2(α), D2, 6-keto-prostaglandin F1(α), and thromboxane B2 (PGE, PGF2(α), PGD2, 6-keto-PGF1(α), TXB2, respectively) were assayed by radioimmunoassay. Results with airway tissue were compared with subpleural parenchymal fragments from the same lungs similarly challenged. Spontaneous generation of prostacyclin (PGI2), as measured by its stable metabolite 6-keto-PGF1(α), exceeded by two- to threefold other spontaneous AACM release in both bronchial and parenchymal fragments. In airway antigen produced variable AACM responses, but in general the rank order was 6-keto-PGF1(α) > PGE is approx. the same as PGF2(α) > PGD2 > TXB2. The rank for antigen-induced AACM release from parenchyma was 6-keto-PGF1(α) is approx. the same as PGD2 > > PGF2(α) > TXB2 is approx. the same as PGE. In airway, as in parenchyma, very little AACM production during anaphylaxis can be attributed to smooth muscle contraction per se. Histamine released from bronchi (0.67 ± 0.30 μg/g lung) was significantly less than from parenchyma (3.7 ± 0.70 μg/g) despite comparable histamine content. At comparable levels of histamine release, the parenchyma produced greater quantities than bronchi of all AACMs except PGE. The comparatively limited bronchial capacity to generate PGF2(α), PGD2, TXB2, and histamine (airway constrictors) along with predominant generation of PGI2 and PGE (airway relaxants) may help preserve airway patency.",
author = "Schulman, {E. S.} and Adkinson, {N Franklin} and Newball, {H. H.}",
year = "1982",
language = "English (US)",
volume = "53",
pages = "589--595",
journal = "Journal of Applied Physiology",
issn = "0161-7567",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Cyclooxygenase metabolites in human lung anaphylaxis

T2 - Airway vs. parenchyma

AU - Schulman, E. S.

AU - Adkinson, N Franklin

AU - Newball, H. H.

PY - 1982

Y1 - 1982

N2 - We studied the generation of arachidonic acid cyclooxygenase metabolites (AACMs) during in vitro anaphylaxis of passively sensitized human lung parenchymal and airway fragments. Prostaglandins E, F2(α), D2, 6-keto-prostaglandin F1(α), and thromboxane B2 (PGE, PGF2(α), PGD2, 6-keto-PGF1(α), TXB2, respectively) were assayed by radioimmunoassay. Results with airway tissue were compared with subpleural parenchymal fragments from the same lungs similarly challenged. Spontaneous generation of prostacyclin (PGI2), as measured by its stable metabolite 6-keto-PGF1(α), exceeded by two- to threefold other spontaneous AACM release in both bronchial and parenchymal fragments. In airway antigen produced variable AACM responses, but in general the rank order was 6-keto-PGF1(α) > PGE is approx. the same as PGF2(α) > PGD2 > TXB2. The rank for antigen-induced AACM release from parenchyma was 6-keto-PGF1(α) is approx. the same as PGD2 > > PGF2(α) > TXB2 is approx. the same as PGE. In airway, as in parenchyma, very little AACM production during anaphylaxis can be attributed to smooth muscle contraction per se. Histamine released from bronchi (0.67 ± 0.30 μg/g lung) was significantly less than from parenchyma (3.7 ± 0.70 μg/g) despite comparable histamine content. At comparable levels of histamine release, the parenchyma produced greater quantities than bronchi of all AACMs except PGE. The comparatively limited bronchial capacity to generate PGF2(α), PGD2, TXB2, and histamine (airway constrictors) along with predominant generation of PGI2 and PGE (airway relaxants) may help preserve airway patency.

AB - We studied the generation of arachidonic acid cyclooxygenase metabolites (AACMs) during in vitro anaphylaxis of passively sensitized human lung parenchymal and airway fragments. Prostaglandins E, F2(α), D2, 6-keto-prostaglandin F1(α), and thromboxane B2 (PGE, PGF2(α), PGD2, 6-keto-PGF1(α), TXB2, respectively) were assayed by radioimmunoassay. Results with airway tissue were compared with subpleural parenchymal fragments from the same lungs similarly challenged. Spontaneous generation of prostacyclin (PGI2), as measured by its stable metabolite 6-keto-PGF1(α), exceeded by two- to threefold other spontaneous AACM release in both bronchial and parenchymal fragments. In airway antigen produced variable AACM responses, but in general the rank order was 6-keto-PGF1(α) > PGE is approx. the same as PGF2(α) > PGD2 > TXB2. The rank for antigen-induced AACM release from parenchyma was 6-keto-PGF1(α) is approx. the same as PGD2 > > PGF2(α) > TXB2 is approx. the same as PGE. In airway, as in parenchyma, very little AACM production during anaphylaxis can be attributed to smooth muscle contraction per se. Histamine released from bronchi (0.67 ± 0.30 μg/g lung) was significantly less than from parenchyma (3.7 ± 0.70 μg/g) despite comparable histamine content. At comparable levels of histamine release, the parenchyma produced greater quantities than bronchi of all AACMs except PGE. The comparatively limited bronchial capacity to generate PGF2(α), PGD2, TXB2, and histamine (airway constrictors) along with predominant generation of PGI2 and PGE (airway relaxants) may help preserve airway patency.

UR - http://www.scopus.com/inward/record.url?scp=0019959276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019959276&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 589

EP - 595

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 0161-7567

IS - 3

ER -